WEST PHARMACEUTICAL SERVICES, INC. Variable Lease, Cost
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Variable Lease, Cost of $3.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. variable lease, cost for the quarter ending 2026-06-30 was $3.00M, a 20.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. variable lease, cost for the quarter ending 2026-03-31 was $2.50M, a 13.79% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. variable lease, cost for the quarter ending 2025-12-31 was $1.80M, a 33.33% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. variable lease, cost for the quarter ending 2025-09-30 was $2.90M, a 16.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. variable lease, cost for fiscal 2025 was $10.10M, a 12.22% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. variable lease, cost for fiscal 2024 was $9.00M, a 63.64% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. variable lease, cost for fiscal 2023 was $5.50M, a 19.12% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. variable lease, cost for fiscal 2022 was $6.80M, a 41.67% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00M 10-Q · filed 2026-07-23 | $5.50M 10-Q · filed 2026-07-23 | $7.30M derived: sum of 3 quarters · filed 2026-07-23 | $10.20M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $2.50M 10-Q · filed 2026-04-23 | $4.30M derived: sum of 2 quarters · filed 2026-04-23 | $7.20M derived: sum of 3 quarters · filed 2026-04-23 | $9.70M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $4.70M derived: sum of 2 quarters · filed 2026-02-17 | $7.20M derived: sum of 3 quarters · filed 2026-07-23 | $10.10M 10-K · filed 2026-02-17 |
| 2025-09-30 | $2.90M 10-Q · filed 2025-10-23 | $5.40M derived: sum of 2 quarters · filed 2026-07-23 | $8.30M 10-Q · filed 2025-10-23 | $11.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $2.50M 10-Q · filed 2026-07-23 | $5.40M 10-Q · filed 2026-07-23 | $8.10M derived: sum of 3 quarters · filed 2026-07-23 | $10.60M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $2.90M 10-Q · filed 2026-04-23 | $5.60M derived: sum of 2 quarters · filed 2026-04-23 | $8.10M derived: sum of 3 quarters · filed 2026-04-23 | $10.00M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $5.20M derived: sum of 2 quarters · filed 2026-02-17 | $7.10M derived: sum of 3 quarters · filed 2026-02-17 | $9.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $2.50M 10-Q · filed 2025-10-23 | $4.40M derived: sum of 2 quarters · filed 2025-10-23 | $6.30M 10-Q · filed 2025-10-23 | $7.40M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $1.90M 10-Q · filed 2025-07-24 | $3.80M 10-Q · filed 2025-07-24 | $4.90M derived: sum of 3 quarters · filed 2026-02-17 | $6.30M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $1.90M 10-Q · filed 2025-04-24 | $3.00M derived: sum of 2 quarters · filed 2026-02-17 | $4.40M derived: sum of 3 quarters · filed 2026-02-17 | $5.70M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.50M derived: sum of 2 quarters · filed 2026-02-17 | $3.80M derived: sum of 3 quarters · filed 2026-02-17 | $5.50M 10-K · filed 2026-02-17 |
| 2023-09-30 | $1.40M 10-Q · filed 2024-10-24 | $2.70M derived: sum of 2 quarters · filed 2024-10-24 | $4.40M 10-Q · filed 2024-10-24 | $6.50M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.30M 10-Q · filed 2024-07-25 | $3.00M 10-Q · filed 2024-07-25 | $5.10M derived: sum of 3 quarters · filed 2025-02-18 | $7.40M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.70M 10-Q · filed 2024-04-25 | $3.80M derived: sum of 2 quarters · filed 2025-02-18 | $6.10M derived: sum of 3 quarters · filed 2025-02-18 | $7.10M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $4.40M derived: sum of 2 quarters · filed 2025-02-18 | $5.40M derived: sum of 3 quarters · filed 2025-02-18 | $6.80M 10-K · filed 2025-02-18 |
| 2022-09-30 | $2.30M 10-Q · filed 2023-10-26 | $3.30M derived: sum of 2 quarters · filed 2023-10-26 | $4.70M 10-Q · filed 2023-10-26 | $6.20M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $1.00M 10-Q · filed 2023-07-27 | $2.40M 10-Q · filed 2023-07-27 | $3.90M derived: sum of 3 quarters · filed 2024-02-20 | $5.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $1.40M 10-Q · filed 2023-04-27 | $2.90M derived: sum of 2 quarters · filed 2024-02-20 | $4.00M derived: sum of 3 quarters · filed 2024-02-20 | $5.40M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $2.60M derived: sum of 2 quarters · filed 2024-02-20 | $4.00M derived: sum of 3 quarters · filed 2024-02-20 | $4.80M 10-K · filed 2024-02-20 |
| 2021-09-30 | $1.10M 10-Q · filed 2022-10-27 | $2.50M derived: sum of 2 quarters · filed 2022-10-27 | $3.30M 10-Q · filed 2022-10-27 | $4.30M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $1.40M 10-Q · filed 2022-07-28 | $2.20M 10-Q · filed 2022-07-28 | $3.20M derived: sum of 3 quarters · filed 2023-02-21 | $4.40M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $800.00K 10-Q · filed 2022-04-28 | $1.80M derived: sum of 2 quarters · filed 2023-02-21 | $3.00M derived: sum of 3 quarters · filed 2023-02-21 | $3.80M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $2.20M derived: sum of 2 quarters · filed 2023-02-21 | $3.00M derived: sum of 3 quarters · filed 2023-02-21 | $3.80M 10-K · filed 2023-02-21 |
| 2020-09-30 | $1.20M 10-Q · filed 2021-10-28 | $2.00M derived: sum of 2 quarters · filed 2021-10-28 | $2.80M 10-Q · filed 2021-10-28 | $3.80M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $800.00K 10-Q · filed 2021-07-30 | $1.60M 10-Q · filed 2021-07-30 | $2.60M derived: sum of 3 quarters · filed 2022-02-22 | $3.40M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $800.00K 10-Q · filed 2021-04-30 | $1.80M derived: sum of 2 quarters · filed 2022-02-22 | $2.60M derived: sum of 3 quarters · filed 2022-02-22 | $3.50M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.80M derived: sum of 2 quarters · filed 2022-02-22 | $2.70M derived: sum of 3 quarters · filed 2022-02-22 | $3.30M 10-K · filed 2022-02-22 |
| 2019-09-30 | $800.00K 10-Q · filed 2020-10-23 | $1.70M derived: sum of 2 quarters · filed 2020-10-23 | $2.30M 10-Q · filed 2020-10-23 | |
| 2019-06-30 | $900.00K 10-Q · filed 2020-07-24 | $1.50M 10-Q · filed 2020-07-24 | ||
| 2019-03-31 | $600.00K 10-Q · filed 2020-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |